Iroquois Capital

North America, Tennessee, United States, Nashville

Description

Iroquois Capital, a private equity firm, specializes in seed- to late-stage, turnaround, growth capital, and PIPE investments.

Investor Profile

Iroquois Capital has backed more than 16 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 13 exits across its portfolio.

Investment Focus Highlights

Concentrates on Series Unknown, Post Ipo Equity, Private Equity rounds (top funding stages).
Majority of deals are located in United States, United Kingdom, China.
Strong thematic focus on Biotechnology, Medical, Health Care.

Stage Focus

Series Unknown (50%)
Post Ipo Equity (31%)
Private Equity (6%)
Series B (6%)
Series C (6%)

Country Focus

United States (81%)
United Kingdom (13%)
China (6%)

Industry Focus

Biotechnology
Medical
Health Care
Biopharma
Pharmaceutical
Therapeutics
Software
Medical Device
Information Technology
Supply Chain Management

FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Iroquois Capital frequently co-invest with?

Downsview Capital

North America, Illinois, United States, Deerfield

Co-Investments: 6

Whalehaven Capital Fund

North America, Ontario, Canada, Toronto

Co-Investments: 3

Dafna Capital Management

Dafna Capital Management

North America, California, United States, Los Angeles

Co-Investments: 3

Nite Capital Management

North America, Illinois, United States, Libertyville

Co-Investments: 4

Alpha Capital

North America, Illinois, United States, Chicago

Co-Investments: 4

Heights Capital Management

Heights Capital Management

North America, California, United States, San Francisco

Co-Investments: 5

Midsummer Capital

Midsummer Capital

North America, New York, United States, New York

Co-Investments: 2

ArmaVir Partners

ArmaVir Partners

North America, New York, United States, New York

Co-Investments: 5

Perceptive Advisors

Perceptive Advisors

North America, New York, United States, New York

Co-Investments: 2

Highbridge Capital Management

Highbridge Capital Management

North America, New York, United States, New York

Co-Investments: 5

Which angels does Iroquois Capital often collaborate with?

Nathan Gantcher

North America, New York, United States, New York

Shared Deals: 1

North America, New York, United States, New York

Shared Deals: 1

North America, New York, United States, New York

Shared Deals: 1

What are some of recent deals done by Iroquois Capital?

Stamford, Connecticut, United States

RS Metrics provides asset-level environmental, climate, and physical risk metrics as SAAS on Google Cloud Marketplace

AnalyticsArtificial Intelligence (AI)Business IntelligenceEnvironmental ConsultingMachine LearningPredictive AnalyticsSoftware

Series BOct 1, 2017

Amount Raised: $5,000,000

Covenant Physician Partners

Nashville, Tennessee, United States

Covenant Physician Partners is a privately-held owner and operator of ambulatory surgery centers.

Health CareMedicalMedical Device

Series CFeb 8, 2013

Amount Raised: $35,000,000

Cascadian Therapeutics

Seattle, Washington, United States

Cascadian Therapeutics is a bio-pharmaceutical company that researches, develops, and sells therapeutic products for treatment of cancer.

BiotechnologyHealth CareTherapeutics

Post Ipo EquitySep 24, 2010

Amount Raised: $14,900,000

Raptor Pharmaceuticals

Novato, California, United States

Raptor is a NASDAQ-listed biopharmaceutical company with the mission to develop and commercialize life-altering therapeutics.

BiopharmaBiotechnologyGeneticsTherapeutics

Post Ipo EquityAug 9, 2010

Amount Raised: $15,000,000

Princeton, New Jersey, United States

Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.

BiopharmaBiotechnologyHealth CareMedical

Series UnknownJul 2, 2010

Amount Raised: $5,904,277

Sevion Therapeutics

San Diego, California, United States

Sevion is a biopharmaceutical company which discovers and develops entirely new therapeutic classes for the treatment of cancer.

BiopharmaBiotechnologyPharmaceuticalTherapeutics

Post Ipo EquityMar 29, 2010

Amount Raised: $11,500,000

Albuquerque, New Mexico, United States

Biomoda operates as an in vitro diagnostics company that develops assays and tests to detect cancer.

BiotechnologyHealth DiagnosticsMedical

Series UnknownMar 16, 2010

Amount Raised: $1,000,000

Shenzhen, Guangdong, China

SinoHub was a one-stop-shop for all electronic component supply chain services.

ElectronicsHardwareManagement Information SystemsManufacturingSoftwareSupply Chain Management

Series UnknownFeb 24, 2010

Amount Raised: $4,610,000

Delray Beach, Florida, United States

VeriTeQ is a technology company focused on animal and emergency identification solutions.

Information TechnologyMedical DeviceMobileRFID

Series UnknownFeb 4, 2010

Amount Raised: $1,540,000

Vienna, Virginia, United States

CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.

BiotechnologyHealth CareMedical

Post Ipo EquityAug 20, 2009

Amount Raised: $4,400,000

Find More Investors Like Iroquois Capital

Discover similar investors in our database and build your perfect investor list.

post_ipo_equity Investors Investors in Nashville Browse All Investors Top Investors

Need help with your fundraising strategy?Read our fundraising guides

Iroquois Capital | Pipeseed